Sign in

Thomas Woods

Director at BAC
Board

About Thomas Woods

Thomas D. Woods (age 72) is an independent director at Bank of America (BAC), serving since April 2016. He is a veteran financial services executive and former Vice Chairman and Senior EVP at CIBC, with prior roles as CFO and Chief Risk Officer, bringing deep risk management, financial reporting, and corporate strategy expertise to BAC’s board. He is independent under NYSE and BAC’s categorical standards and attended at least 75% of Board and committee meetings in 2024 .

Past Roles

OrganizationRoleTenureCommittees/Impact
Canadian Imperial Bank of Commerce (CIBC)Vice Chairman & Senior EVP2013–2014Senior leadership during post-crisis period
CIBCChief Risk Officer2008–2013Led risk culture; chaired Asset Liability Committee; regulator liaison
CIBCChief Financial Officer2000–2008Financial reporting & controls
CIBC/Predecessors (Wood Gundy)Various senior roles incl. Controller, CFO of CIBC World Markets; Head of Canadian Corporate BankingBegan 1977Investment banking and corporate banking leadership
Hydro One Limited (TSX)Chair of Board2018–2019Governance oversight
Alberta Investment Management Corp.Director2015–2024Oversight at major Canadian asset manager
Jarislowsky Fraser LimitedDirector2016–2018Governance at investment manager
DBRS Limited/DBRS, Inc.Director2015–2016Credit ratings governance
TMX Group Inc.Director2012–2014Market infrastructure oversight

External Roles

OrganizationRoleTenureCommittees/Impact
Merrill Lynch International (MLI, BAC UK broker-dealer subsidiary)Director; Chair, Risk Committee; Member, Governance CommitteeCurrentRisk oversight for UK subsidiary
BofA Securities Europe S.A. (BofASE, BAC French broker-dealer subsidiary)DirectorAppointed Jan 29, 2024European subsidiary oversight
Institute of Corporate Directors (Institut des Administrateurs de Sociétés)Chair, Board of DirectorsCurrentDirector education & governance standards
Cordiant Capital Inc.Advisory committee memberCurrentGlobal infrastructure advisory
University of TorontoCollege of ElectorsCurrentUniversity governance
Catholic Health Sponsors of OntarioDirectorCurrentNonprofit healthcare governance
St. Michael’s Hospital FoundationDirectorCurrentPhilanthropy oversight

Other U.S.-listed public company boards: None .

Board Governance

  • Committees: Corporate Governance Committee (CGC) member and Enterprise Risk Committee (ERC) member; not a committee chair at BAC (CGC had 7 meetings; ERC had 11 meetings in 2024) .
  • Independence: Affirmed independent along with all directors except the CEO; ordinary-course relationships reviewed did not impair independence .
  • Attendance: All incumbent directors (including Woods) attended at least 75% of aggregate Board and committee meetings in 2024; Board held 13 independent executive sessions .
  • Expertise: Financial services, risk management, and audit/financial reporting—aligned with ERC oversight of BAC’s Risk Framework and cybersecurity risk, and CGC’s governance practices .

Fixed Compensation

Component (2024)Amount (USD)Notes
Cash retainer$120,000 Non-management director annual cash award
Stock awards (restricted stock)$270,000 One-year vest; dividends accrue and pay at vest
Other compensation$231,262 Subsidiary board retainers: MLI (£110,000) and BofASE (€90,000, prorated); converted at 0.78 GBP/USD and 0.92 EUR/USD
Total (2024)$621,262

Program updates effective 2025 (boardwide): non-management director cash increased to $130,000 and restricted stock increased to $280,000; committee chair cash retainers increased to $50,000; Lead Independent Director incremental restricted stock increased to $175,000; new director compensation limit in BACEP of $1,000,000 total value per year (cash + shares), subject to limited exceptions .

  • Deferral & Holding: Directors may defer cash or stock via the Director Deferral Plan; directors must hold restricted stock until termination; hedging and pledging equity-based awards are prohibited .

Performance Compensation

Directors do not receive performance-based equity with metrics; annual director equity is time-based restricted stock with a one-year vest and dividend accrual payable at vest. No options are granted to directors .

Other Directorships & Interlocks

CompanyTypeRolePotential Interlock/Conflict Assessment
MLI (UK)BAC subsidiaryDirector; Chair Risk Committee; Governance Committee memberAligned with BAC oversight; compensated via subsidiary retainers; ordinary course
BofASE (France)BAC subsidiaryDirectorAligned with BAC EU operations; compensated via subsidiary retainers
U.S.-listed boardsExternalNoneNo external U.S.-listed interlocks
  • Related-party transactions: BAC reviewed ordinary-course relationships (financial products/services provided to directors or affiliated entities; purchases from entities where directors or immediate family were executives) and determined they were below thresholds and did not impair independence; Woods is among directors with such ordinary-course relationships reviewed . BAC’s related-person transaction policy requires CGC approval/ratification considering arm’s-length terms, materiality, independence, reputational risk, and regulatory acceptability .

Expertise & Qualifications

  • Risk management leader: Former CRO and CFO at CIBC; chaired ALCO; regulator liaison—directly relevant to ERC responsibilities for risk appetite, CCAR, and cybersecurity oversight .
  • Financial reporting & audit: CFO experience and audit/financial reporting expertise—supports Audit/financial literacy standards .
  • International perspective: Service on BAC’s UK and EU broker-dealer boards helps oversee European subsidiary risks .

Equity Ownership

As of March 3, 2025Shares/UnitsDetails
Common stock beneficially owned118,460 Includes 50,003 shares with shared voting/investment power with spouse; and 25,000 shares with shared investment power with spouse
Deferred director stock awardsNone shown
Unvested director restricted stock/units (12/31/24)3,796 From 2024 director grant
Ownership as % of shares outstanding<1% Directors and executive officers each <1%
Options outstandingNone No outstanding stock options
Hedging/PledgingProhibited for directors; stock must be retained until service ends

Governance Assessment

  • Board effectiveness: Woods’ extensive CRO/CFO background strengthens ERC’s risk oversight and CGC’s governance rigor; his subsidiary board leadership (MLI Risk Committee Chair) adds practical risk governance experience in regulated markets .
  • Independence & attendance: Independent, with 2024 attendance ≥75%; Board held 13 executive sessions, maintaining robust independent oversight .
  • Compensation alignment: Director pay comprises cash and time-based restricted stock; holding requirements, hedging/pledging prohibitions, and new annual cap enhance alignment and mitigate governance risk .
  • Conflicts & related-party exposure: Ordinary-course relationships reviewed and below thresholds; subsidiary board retainers disclosed in “Other compensation” with transparent conversion; independence affirmed—low conflict risk signaled .
  • Signals for investors: Strong risk expertise and subsidiary oversight support confidence in BAC’s risk governance; clear director compensation governance and limits reduce pay-related red flags. BAC’s say-on-pay support at 91.4% underscores shareholder confidence in compensation governance .

RED FLAGS: None disclosed specific to Woods. No pledging or hedging of BAC stock; no external U.S.-listed interlocks; related-party dealings reviewed and below thresholds .

Context: BAC emphasizes independent leadership (Lead Independent Director), rigorous board evaluation, and shareholder engagement; 2024 say-on-pay approval 91.4% reflects governance support .

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%